Title : TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.

Pub. Date : 2015 Feb

PMID : 25385265






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma. Platinum tumor protein p53 Homo sapiens
2 Patients with oncomorphic TP53 mutations demonstrated significantly worse PFS, a 60% higher risk of recurrence (HR=1.60, 95% confidence intervals 1.09, 2.33, p=0.015), and higher rates of platinum resistance (chi(2) test p=0.0024) when compared with single nucleotide mutations not categorized as oncomorphic. Platinum tumor protein p53 Homo sapiens